Francesca Fusco

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

NSCLC in Vulnerable and Special Populations: Toward Personalized Care.

NSCLC in Vulnerable and Special Populations: Toward Personalized Care.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 15, 2025

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.

Journal: JTO clinical and research reports

Published: September 09, 2025

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer.

Journal: JAMA oncology

Published: May 22, 2025

Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.

Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.

Journal: Journal for immunotherapy of cancer

Published: May 01, 2025

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study.

First-line immunotherapy with or without chemotherapy versus BRAF plus MEK inhibitors in BRAFV600E-mutated metastatic non-small-cell lung cancer (FRONT-BRAF): a multicentre, retrospective cohort study.

Journal: The Lancet. Oncology

Published: February 28, 2025

Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort.

Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort.

Journal: BMC cancer

Published: January 09, 2025

DESTINY of Immunotherapy in Patients With HER2 Mutant Lung Cancer: Case Report.

DESTINY of Immunotherapy in Patients With HER2 Mutant Lung Cancer: Case Report.

Journal: JTO clinical and research reports

Published: November 19, 2024

Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC.

Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 08, 2024

A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy.

A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: March 27, 2024

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC.

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC.

Journal: Frontiers in oncology

Published: May 27, 2023

ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.

ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 23, 2023

Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review.

Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review.

Journal: Cancers

Published: April 02, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026